Cargando…

Positive Status of Epstein-Barr Virus as a Biomarker for Gastric Cancer Immunotherapy: A Prospective Observational Study

Immunotherapy has exhibited promising but controversial results in gastric cancer; determining criteria for choosing the appropriate target population is still problematic. Epstein-Barr virus (EBV)-associated gastric carcinoma (EBVaGC) exhibits distinctive genomic aberrations and clinicopathologic f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Tong, Liu, Yiqiang, Zhang, Zhening, Zhang, Xiaotian, Gong, Jifang, Qi, Changsong, Li, Jian, Shen, Lin, Peng, Zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Clinical Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144749/ https://www.ncbi.nlm.nih.gov/pubmed/32134806 http://dx.doi.org/10.1097/CJI.0000000000000316

Ejemplares similares

Clinicopathological Characteristics and Response to Chemotherapy in Treatment-Naive Epstein–Barr Virus Associated Gastric Cancer: A Retrospective Study
por: Xie, Tong, et al.
Publicado: (2021)

Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer
por: Bai, Yuezong, et al.
Publicado: (2022)

Appropriate PD-L1 Cutoff Value for Gastric Cancer Immunotherapy: A Systematic Review and Meta-Analysis
por: Xie, Tong, et al.
Publicado: (2021)

Immune checkpoint inhibitors for treatment of advanced gastric or gastroesophageal junction cancer: Current evidence and future perspectives
por: Zhang, Zhening, et al.
Publicado: (2020)

Peripheral Blood Biomarkers Predictive of Efficacy Outcome and Immune-Related Adverse Events in Advanced Gastrointestinal Cancers Treated with Checkpoint Inhibitors
por: Zhang, Zhening, et al.
Publicado: (2022)

Pulmonary lymphangitis carcinomatosis: A peculiar presentation clustering in MET‐amplified gastric cancer
por: Zhang, Zhening, et al.
Publicado: (2023)

Genomic assays for Epstein–Barr virus-positive gastric adenocarcinoma
por: Gulley, Margaret L
Publicado: (2015)

The Methylation Status and Expression of Epstein-Barr Virus Early Genes BARF1 and BHRF1 in Epstein-Barr Virus-Associated Gastric Carcinomas
por: Li, Jing, et al.
Publicado: (2017)

Immunotherapy for Epstein-Barr Virus-Related Lymphomas
por: Kennedy-Nasser, Alana A., et al.
Publicado: (2009)

Epstein-Barr Virus in Gastric Carcinoma
por: Nishikawa, Jun, et al.
Publicado: (2014)

Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer
por: Singh, Shyam, et al.
Publicado: (2017)

Association of Lymphocyte-to-Monocyte Ratio With Survival in Advanced Gastric Cancer Patients Treated With Immune Checkpoint Inhibitor
por: Chen, Yang, et al.
Publicado: (2021)

The oncogenic role of Epstein–Barr virus‐encoded microRNAs in Epstein–Barr virus‐associated gastric carcinoma
por: Zhang, Jinglin, et al.
Publicado: (2017)

Role of Exosomes and Their Potential as Biomarkers in Epstein-Barr Virus-Associated Gastric Cancer
por: Kim, Binnari, et al.
Publicado: (2023)

Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis
por: Camargo, M C, et al.
Publicado: (2011)

Establishment of Epstein‐Barr Virus‐positive Human Gastric Epithelial Cell Lines
por: Tajima, Masako, et al.
Publicado: (1998)

Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer
por: Zhang, Li, et al.
Publicado: (2021)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Expression of Epstein-Barr Virus Gene and Clonality of Infiltrated T Lymphocytes in Epstein-Barr Virus-associated Gastric Carcinoma
por: Lee, Jae Myun, et al.
Publicado: (2011)

Positivity of both plasma Epstein–Barr virus DNA and serum Epstein–Barr virus capsid specific immunoglobulin A is a better prognostic biomarker for nasopharyngeal carcinoma
por: Zhao, Fei-Peng, et al.
Publicado: (2014)

Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapy
por: Pender, Michael P, et al.
Publicado: (2014)

Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
por: Bar-Or, Amit, et al.
Publicado: (2020)

Status of kinases in Epstein-Barr virus and Helicobacter pylori Coinfection in gastric Cancer cells
por: Sonkar, Charu, et al.
Publicado: (2020)

Epstein-Barr Virus (EBV)-associated Gastric Carcinoma
por: Iizasa, Hisashi, et al.
Publicado: (2012)

Epstein-Barr virus gastric ulcer associated with ruxolitinib
por: Kusano, Yoshiharu, et al.
Publicado: (2016)

Evaluation of plasma Epstein–Barr virus DNA as a biomarker for Epstein–Barr virus–associated Hodgkin lymphoma
por: Usha, Masuma Khatun, et al.
Publicado: (2021)

Variations of Epstein-Barr Virus Nuclear Antigen 1 in Epstein-Barr Virus-Associated Gastric Carcinomas from Guangzhou, Southern China
por: Chen, Jian-ning, et al.
Publicado: (2012)

Epstein-Barr Virus is Associated with Gastric Cancer Precursor: Atrophic Gastritis
por: Zhao, Kai, et al.
Publicado: (2022)

Differentiated tumor immune microenvironment of Epstein–Barr virus-associated and negative gastric cancer: implication in prognosis and immunotherapy
por: Ma, Jing, et al.
Publicado: (2017)

Epstein–Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2014)

Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein–Barr Virus-Associated Malignancies
por: Zheng, Xueyi, et al.
Publicado: (2022)

Observational cohort study of clinical outcome in Epstein–Barr virus associated gastric cancer patients
por: Qiu, Miao-Zhen, et al.
Publicado: (2020)

Associations of Epstein-Barr Virus-Positive Gastric Adenocarcinoma with Circulating Mediators of Inflammation and Immune Response
por: Camargo, M. Constanza, et al.
Publicado: (2018)

Regulation of proliferation and invasion by the IGF signalling pathway in Epstein‐Barr virus‐positive gastric cancer
por: Jeong, Inhye, et al.
Publicado: (2018)

Epstein–Barr virus-positive ulcer in the oral cavity
por: Ramos-Baena, Jose David, et al.
Publicado: (2021)

Interaction of Epstein-Barr virus genes with human gastric carcinoma transcriptome
por: Zhang, Ruiyuan, et al.
Publicado: (2017)

CT041 CAR T cell therapy for Claudin18.2-positive metastatic pancreatic cancer
por: Qi, Changsong, et al.
Publicado: (2023)

Epstein–Barr virus serology and gastric cancer incidence and survival
por: Koshiol, J, et al.
Publicado: (2007)

The conundrum of the Epstein-Barr virus-associated gastric carcinoma in the Americas
por: Carrasco-Avino, Gonzalo, et al.
Publicado: (2017)

Clinical Importance of Epstein–Barr Virus-Associated Gastric Cancer
por: Nishikawa, Jun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8j9d1vdu5k8v4cjpcanld0qdvr